Laureen DeBuono - 29 Jul 2021 Form 3/A - Amendment Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Director
Signature
/s/ Josh Seidenfeld, Attorney-in-Fact for Laureen DeBuono
Issuer symbol
RANI
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3/A - Amendment
Filing time
02 Aug 2021, 19:48:30 UTC
Date Of Original Report
29 Jul 2021
Next filing
06 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RANI Stock Option (Right to Buy) 29 Jul 2021 Class A Common Stock 135,768 $9.45 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 1/3rd of the shares of the shares subject to the option vests on April 20, 2022; and 1/36th of the shares subject to the option vest monthly thereafter over the following two years.
F2 This amendment is being filed to correctly reflect the shares held.
F3 This amendment is being filed to correctly reflect the exercise price of the Stock Option.